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ABSTRACT
OBJECTIVE: To analyze the prevalence of cigarette smoking in individuals 
with severe mental illnesses in a large urban centre of a middle income 
country.
METHODS: Cross-sectional study carried out in São Paulo. The sample 
(N=192) comprised individuals diagnosed with severe mental illnesses who had 
contact with public psychiatric care services from September to November 1997 
and were aged between 18 and 65 years. Prevalence of daily tobacco smoking 
in the 12 months previous to the interview and characteristics associated were 
studied.
RESULTS: Out of 192 subjects with severe mental illnesses interviewed, 115 
(59.9%; 95% CI: 52.6%; 66.9%) reported smoking cigarettes on a daily basis. 
Male gender, marital status separated or widowed, irregular use of neuroleptic 
drugs and history of ten or more psychiatric admissions were independently 
associated with cigarette smoking.
CONCLUSIONS: The prevalence of cigarette smoking in the present sample 
was higher than that found in the general Brazilian population. Mental care 
services should implement non-smoking policies and mental health providers 
need to help patients with severe mental illness who want to quit smoking.
KEY WORDS: Mentally ill persons. Diagnosis, dual (Psychiatry). 
Mental disorders, epidemiology. Tobacco use disorder, epidemiology. 
Mental health services. Cross-sectional studies.
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RESUMO
OBJETIVO: Analisar a prevalência de tabagismo em amostra de indivíduos 
com transtornos mentais graves em um grande centro urbano de um país 
emergente.
MÉTODOS: Estudo transversal realizado no município de São Paulo. A 
amostra (N=192) foi composta por indivíduos com diagnóstico de transtorno 
mental grave que tiveram contato com serviços psiquiátricos do setor público 
de setembro a novembro de 1997 e tinham idade entre 18 e 65 anos. O uso 
diário de cigarro nos 12 meses anteriores à entrevista e as características 
associadas a esse consumo foram investigados.
RESULTADOS: Dos 192 indivíduos com transtornos mentais graves 
entrevistados, 115 (59,9%; IC 95%: 52,6%;66,9%) referiram ter feito uso 
diário de cigarros. Ser do sexo masculino, ser separado ou viúvo, fazer uso 
irregular de neurolépticos e ter história de dez ou mais internações anteriores 
mostraram-se independentemente associados ao tabagismo.
CONCLUSÕES: A prevalência de tabagismo na amostra de indivíduos com 
transtornos mentais graves foi maior que a encontrada na população geral 
brasileira. Serviços de saúde mental devem promover políticas anti-fumo 
e profi ssionais de saúde mental devem ajudar os portadores de transtornos 
mentais graves que desejarem parar de fumar.
DESCRITORES: Pessoas mentalmente doentes. Diagnóstico duplo 
(Psiquiatria). Transtornos mentais, epidemiologia. Transtorno por 
uso de tabaco, epidemiologia. Serviços de saúde mental. Estudos 
transversais.
Over the past decade, several studies in developed 
countries have reported higher prevalence of cigarette 
smoking among people with severe mental illnesses 
than in the general population.4,7,8,11,18,20 The former 
group consumes more cigarettes per day and is less 
likely to quit smoking than smokers in the general 
population.11,20 There is evidence that individuals with 
schizophrenia have higher mortality rates from cardio-
vascular diseases and cancer than the general population 
and the high prevalence and amount of smoking may be 
one of the reasons for such higher mortality rates.2,4,7,8 
Cigarette smoking is also a risk factor for dyskinesia 
regardless of exposure to antipsychotic medication.15 
Data on prevalence of cigarette smoking among people 
with severe mental illnesses are scarce in low and 
middle income countries. A recent study3 carried out 
in Colombia also found higher prevalence of cigarette 
smoking among individuals with schizophrenia, even 
though the general population had low smoking preva-
lence. On the other hand, a study carried out in India19 
found that the prevalence of current smoking among 
those with diagnosis of schizophrenia was very similar 
to that of the general population. The authors argued 
that lack of fi nancial independence might explain such 
fi nding, through restrictions imposed by the families 
of those with severe mental illnesses. In Brazil, high 
fi nancial dependence is also common among people 
with severe mental illnesses,13 and the prevalence of 
substance misuse among them is much lower than 
that observed in developed countries.14 Therefore, the 
prevalence of cigarette smoking people with severe 
mental illnesses may not follow the pattern seen in 
developed countries.
The objective of the present study was to analyze the 
prevalence and associated factors to cigarette smoking 
in a sample of individuals with severe mental illnesses 
in a large urban centre of a middle income country.
METHODS
A cross-sectional study was carried out in São Paulo, 
Southeastern Brazil. São Paulo is the largest urban 
center in South America, with a population of approxi-
mately 10 million inhabitants. Based on availability of 
all levels of mental care, seven administrative districts 
were chosen, heterogeneous in socioeconomic condi-
tions, and totaling a population of 609,000 inhabitants. 
Public mental care services in these districts included 
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psychiatric hospitals, outpatient clinics, 24-hour psychi-
atric emergency services, day-hospitals and day centers, 
some of which in teaching hospitals. Most services were 
not organized on a catchment area basis.
The sampling frame was built to closely represent 
people suffering from severe mental illnesses living in 
the study area. For this, medical records of all mental 
health services (hospitals, emergency, outpatient clin-
ics, day hospitals) providing public health care and 
most likely to be sought by people with severe mental 
illnesses living in those areas were screened. Selection 
criteria at this stage included: having had at least one 
contact with any of those services in the period from 
September 1st to November 30, 1997; be aged between 
18 and 65 years; having a possible clinical diagnosis 
of functional psychosis; and be living in the study ar-
eas. A sample was then drawn from this list for direct 
interview. Subjects had then to meet ICD-1021 criteria 
for diagnosis of non-affective psychosis (codes F20 to 
F29), bipolar disorder (F30 or F31), or depressive dis-
order with psychotic symptoms (F32.4 or F33.4). The 
sample size was calculated on basis of the precision of 
the prevalence estimate. For an expected prevalence of 
daily smoking of 75%, a sample of 201 subjects would 
yield a 95% confi dence interval of 69% to 81%.
A standardized questionnaire was used to collect 
sociodemographic and socioeconomic data. Psy-
chiatric history was obtained using the Life Chart 
Rating Form.22 Psychiatric diagnoses were obtained 
using the ICD-10 checklist.9 Psychopathology was 
assessed with the Positive and Negative Syndrome 
Scale (PANSS).10 This scale comprises seven items 
for positive psychotic symptoms (such as delusions, 
hallucinations, thought disorder), seven items for nega-
tive psychotic symptoms (such as blunted affect, lack 
of insight, lack of abstract thinking), and 16 items for 
other psychiatric symptoms (such as anxiety, depres-
sion, worry). Each item is scored on a 7-point scale, 
ranging from one (no symptom) to seven (very severe 
symptom). Therefore, the higher the score in each sub-
scale (positive, negative and general psychopathology), 
the more symptomatic the individual is. Patterns of 
substance use, including tobacco, in the 12 months 
prior to the interview, and symptoms of substance 
abuse or dependence in the same period of time were 
assessed using Sections 11 and 12 of the Schedule for 
Clinical Assessment in Neuropsychiatry (SCAN).23 
This instrument allows to classify use as “used any 
form of tobacco at least once in their lifetime,” “used 
it on a regular basis,” “regular use of tobacco in the 
previous 12 months” (i.e., use of any substance almost 
daily during the period), and “met criteria for nicotine 
dependence in the 12 months prior to the interview,” 
according to the ICD-10. Subjects were interviewed 
at home, whenever possible.
The main outcome was daily use of cigarettes in the 
previous 12 months to the interview. Prevalence of daily 
cigarette smoking and related 95% confi dence interval 
(95% CI) were estimated. Associations of cigarette 
smoking with subjects’ characteristics were assessed 
using χ2 tests for categorical exposure variables; χ2 tests 
for linear trend for ordered exposure variables; and 
analysis of variance for continuous exposure variables. 
Prevalence ratios and related 95% CI were calculated. 
Logistic regression was performed to obtain estimates 
of independent associations of individual characteristics 
with daily cigarette smoking. Selection of variables 
to be tested in the logistic regression was based on p-
values <0.25 in the bivariate analysis. Variables were 
kept in the fi nal logistic regression model if they had a 
p-value ≤0.05 according to the likelihood ratio test.
The study was approved by the Research Ethics Com-
mittee of Faculdade de Medicina da Universidade de 
São Paulo. All subjects signed an informed consent 
form agreeing to participate in the study.
RESULTS
The list obtained in the services included 620 names, 
and 404 were drawn to be included in the study sample. 
Of these, 116 (28.7%) had moved to other addresses, 
which were either unknown or too far from São Paulo to 
be visited by the research team, or were unknown in the 
address provided or the address did not exist. Among 
losses, 59 (14.6%) were refusals, 8 (2.0%) had died, 6 
(1.4%) had become homeless, 3 (0.7%) were in prison, 
and six names were replicated in the list. Finally, 206 
(51.0%) subjects were interviewed. Compared to inter-
viewed subjects, non-respondents comprised a slightly 
higher proportion of women (56.1% vs. 47.6%; p=0.09) 
and affective disorders (30.0% vs. 22.8%; p=0.15), 
and were slightly younger (38.2 years vs. 40.0 years; 
p=0.14), though these differences between groups were 
not statistically signifi cant. Fourteen subjects were ex-
cluded from further analyses because they did not meet 
ICD-10 criteria for any psychotic condition according 
to the standardized assessment.
Of the remaining 192 subjects, 102 (53.1%) were men, 
30 (15.6%) had not completed elementary school, 110 
(57.3%) were single, and 91 (47.4%) were born in 
the city of São Paulo (Table 1). Their mean age was 
41.5 years (SD=11.4 years). Monthly family income 
ranged from R$ 100.00 to R$ 10,000.00, with a median 
of R$ 950.00 (R$ 1.00=US$ 1.13). Seventy (36.5%) 
subjects did not have their own source of income, 
relying entirely on relatives and friends to live. The 
most common clinical diagnosis was schizophrenia 
(N=113; 58.9%), and 61 (31.8%) had either bipolar 
disorder or depression with psychotic symptoms. 
Forty (20.8%) subjects had had no previous psychi-
atric admission, and 49 (25.5%) had been admitted to 
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lifetime, and 115 (59.9%; 95% CI: 52.6%;66.9%) 
reported daily smoking in the previous 12 months. Av-
erage consumption was 21.9 (SD=13.5) cigarettes per 
day, with a more intense daily use of 30.1 (SD=19.3). 
Among current smokers, 32 (27.8%) were light smokers 
(one to ten cigarettes per day), 43 (37.4%) were moder-
ate smokers (11 to 20 per day), and 40 (34.8%) heavy 
smokers (more than 21 per day). Ninety-one (47.4%) 
psychiatric hospitals ten or more times during their 
lifetime. In regard to PANSS scores, the mean of posi-
tive symptoms was 11.5 (SD=5.6), negative symptoms 
was 14.8 (SD=8.6), and general symptoms was 25.9 
(SD=8.5) (Table 2).
One-hundred and forty nine (77.6%) subjects reported 
having used any form of tobacco at least once in their 
Table 1. Frequency of current regular use of tobacco and subjects’ characteristics associated. City of São Paulo, Southeastern 
Brazil, 1997. N=192
Variable N Tobacco use (%) RR 95% CI p-value
Gender 0.001
Female 90 43 (47.8) 1 -
Male 102 72 (70.6) 1.48 1.15;1.90
Marital status 0.02
Married/with partner 44 23 (52.3) 1 -
Single 110 63 (57.3) 1.10 0.79;1.52
Separated/widowed 38 29 (76.3) 1.46 1.05;2.04
Place of birth 0.055
São Paulo 91 48 (52.7) 1 -
Other 101 67 (66.3) 1.26 0.99;1.60
Education (years) 0.54
0–3 30 17 (56.7) 1 -
4–8 96 61 (63.5) 1.12 0.79;1.59
9–11 34 17 (50.0) 0.88 0.56;1.40
12 or more 32 20 (62.5) 1.10 0.73;1.67
Age group (years) 0.96
18–24 14 8 (57.1) 1 -
25–34 40 25 (62.5) 1.09 0.65;1.83
35–44 63 39 (61.9) 1.08 0.66;1.77
45–54 42 25 (59.5) 1.04 0.62;1.75
55–65 33 18 (54.5) 0.95 0.55;1.65
Diagnosis 0.98
Schizophrenia 113 67 (59.3) 1 -
Other non-affective psychosis 12 7 (58.3) 0.98 0.60;1.63
Bipolar disorder 46 27 (58.7) 0.99 0.74;1.32
Depression with psychotic symptoms 15 10 (66.7) 1.12 0.76;1.66
Schizoaffective disorder 6 4 (66.7) 1.12 0.63;2.02
Psychiatric admissions 0.04
None 40 24 (60.0) 1 -
1–3 60 28 (46.7) 0.78 0.54;1.13
4–9 43 27 (62.8) 1.05 0.74;1.47
10 or more 49 36 (73.5) 1.22 0.90;1.66
Anti-psychotic medication use* 0.03
Never 26 12 (46.2) 1 -
Sometimes 19 16 (84.2) 1.82 1.15;2.89
Most of the time 145 86 (59.3) 1.29 0.83;1.99
* Two missing values
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subjects met criteria for nicotine dependence in the 12 
months prior to the interview.
Men were more likely to be smokers (p<0.05), as 
well as those who were separated or widowed (Table 
1). Number of psychiatric admissions and irregular 
use of anti-psychotic medication in the previous two 
years were also statistically associated with the out-
come. The logistic regression analysis showed that 
male gender (p<0.001), marital status separated or 
widowed (p=0.003), irregular use of anti-psychotic 
drugs (p=0.02) and history of ten or more psychiatric 
admissions (p=0.016) were independently associated 
with higher odds of being a current smoker.
DISCUSSION
Selection bias was a concern in the present study. In 
most services, the quality of medical records was poor, 
and several fi les were not included in the sampling list 
due to missing information on age, address and clinical 
diagnosis. However, this was more likely to be random, 
not associated with smoking status, which would not 
bias the prevalence estimate. Though non-participa-
tion was high, it is unlikely that this has biased the 
prevalence estimate for daily cigarette smoking. Non-
respondents comprised a slightly higher proportion of 
women, and no association between age or diagnosis 
and daily cigarette smoking was seen. 
Information on cigarette smoking was obtained by 
directly interviewing subjects, and no other source of 
information, such as relatives or medical records, was 
used. This may have contributed to an underestima-
tion of the prevalence of comorbidity. However, such 
information bias is commoner when investigating use 
of heavy drugs, such as cocaine and heroin, than for 
cannabis and nicotine.12 
The study sample consisted of people with severe 
mental illnesses who seek care in public care services. 
It is estimated that about 45% of the population of 
São Paulo has some kind of private health insurance.* 
Nevertheless, at the time the present study, most insur-
ance plans did not cover mental illnesses. Thus, most 
people covered by private health insurance plans would 
have sought psychiatric care in the public sector. The 
area chosen for the study is not representative of the 
entire population of the city of São Paulo, comprising 
areas with above average deprivation indicators. Both 
these aspects limit the generalizability of the study 
fi ndings.
The comparison of the present study results with the 
literature is not straightforward, because there are dif-
ferent defi nitions for current cigarette smoking. Some 
studies use subjective defi nitions, such as “regular 
use,” while others may simply not state how current 
cigarette smoking was defi ned. Bearing that in mind, 
the prevalence of cigarette smoking in the present 
sample was as high as that found in samples of severely 
mentally ill people in developed countries,4,7,8,11,18,20 and 
higher than that found in two studies in developing 
countries.3,19 The prevalence of cigarette smoking found 
in the present sample was much higher than that seen 
in the Brazilian general population. In a recent survey 
of the general Brazilian population in 15 capitals and 
the Federal District, the estimated prevalence of cur-
rent cigarette smoking in São Paulo was 20% among 
people aged 15 and older.** Therefore, individuals with 
severe mental illnesses were three times more likely to 
be current smokers than the general population. Male 
subjects, those separated and with larger number of 
previous psychiatric admissions were more likely to 
be current smokers corroborating the study fi ndings 
in developed and developing countries.3,11,18 No other 
sociodemographic or clinical features of subjects was 
associated with cigarette smoking.
Results from different populations may help to under-
stand determinants of prevalence across populations.17 
In developed countries, consistency between results 
from several studies, showing a strong association be-
tween severe mental illness and tobacco smoking, raised 
hypotheses about individual factors. These are mostly 
related to the disease and psychiatric treatment, which 
may explain individual variation in smoking.6,24 The 
high prevalence of smoking found in the present study 
contrasts with the low prevalence of substance misuse 
in the same population.14 In many societies in low and 
middle income countries, most individuals with severe 
mental illnesses live with and rely upon their families 
to survive.13,19 This may decrease their exposure and 
Table 2. Mean Positive and Negative Syndrome Scale (PANSS) 
scores according to smoking and non-smoking status. City of 









10.7 (4.4) 12.0 (6.1) 0.09
Negative
symptoms**
14.8 (8.3) 14.8 (8.9) 0.98
General
symptoms***
25.4 (7.8) 26.2 (9.0) 0.55
Total score*** 50.9 (17.4) 52.7 (20.1) 0.53
* Three missing values
** Five missing values
*** Four missing values
* Fundação Sistema Estadual de Análise de Dados. Pesquisa de Condições de Vida 2001 - Distribuição dos Indivíduos, segundo Condição de 
Posse de Convênio ou Plano de Saúde, Estado de São Paulo, RMSP e Interior, 1994 – 1998. [Dados não divulgados]
** Ministério da Saúde. Inquérito domiciliar sobre comportamentos de risco e morbidade referida de doenças e agravos não transmissíveis: 
Brasil, 15 capitais e Distrito Federal, 2002-2003. Rio de Janeiro; Instituto Nacional do Câncer; 2004.
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access to alcohol and illicit drugs. However, it seems 
that, for social and cultural reasons, families in São 
Paulo accept that their ill relatives smoke tobacco, and 
even support this habit. In countries where smoking is 
prohibited by familial, cultural and religious practices, 
the prevalence is not much different than that in general 
population,19 reinforcing this assumption. In Brazil, 
smoking is allowed in most psychiatric hospitals, and 
it is common the use of cigarettes to maintain patients 
calm and under control, given as a reward for “good be-
havior” in the ward. Indeed, the prevalence of cigarette 
smoking was higher among those individuals who had 
a story of ten or more psychiatric admissions.
While cancer mortality rates in individuals with severe 
mental illnesses are not consistently high, rates of car-
diovascular and respiratory diseases are usually greater, 
often even twice as high as those found in age-matched 
control populations.2,7,8 The perception that smokers 
with severe mental illnesses would not be suitable for 
smoking cessation interventions is misleading. Indeed, 
a substantial proportion of smokers with schizophrenia 
recognize that smoking is a problem, and a subset of 
them reports they want to quit.16 Some studies have 
even reported promising results in helping individuals 
with schizophrenia quit smoking.1,5,24
In conclusion, tobacco smoking among people with 
severe mental illnesses is likely to be a major problem 
in many developing areas in the world, particularly in 
large urban centers. Consistent anti-tobacco policies 
need be implemented in mental care services, banning 
smoking within health care premises and promoting 
specifi c programs for helping quit smoking. Training of 
mental health providers should include raising aware-
ness of the problem, developing skills to help those with 
severe mental illnesses to stop smoking, and educating 
families and caregivers about health risks associated 
with smoking. If not, those who already suffer from 
such disruptive and disabling conditions will continue 
to suffer the extra burden of smoking-related health 
problems.
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